These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9322003)

  • 1. Diversity of agonist-mediated signal transduction pathways in human platelets.
    Saeed SA; Shah BH
    Adv Exp Med Biol; 1997; 407():531-5. PubMed ID: 9322003
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of phosphatidylinositol 3-kinase in human platelet aggregation.
    Shah BH; Saeed SA; Shamim G; Nawaz Z; Gilani AH
    Biochem Soc Trans; 1997 Nov; 25(4):S600. PubMed ID: 9450028
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between the effects of the rapid recombinant insulin analog Lispro (Lys B28, Pro B29) and those of human regular insulin on platelet cyclic nucleotides and aggregation.
    Russo I; Massucco P; Mattiello L; Anfossi G; Trovati M
    Thromb Res; 2003 Mar; 109(5-6):323-7. PubMed ID: 12818257
    [No Abstract]   [Full Text] [Related]  

  • 4. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine.
    Shah BH; Saeed SA
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):157-64. PubMed ID: 8556270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for phosphatidylinositol 3-kinase in platelet aggregation in response to low, but not high, concentrations of PAF or thrombin.
    Lauener RW; Stevens CM; Sayed MR; Salari H; Duronio V
    Biochim Biophys Acta; 1999 Nov; 1452(2):197-208. PubMed ID: 10559473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of human platelets by platelet activating factor.
    Chesney CM; Pifer DD; Huch KM
    Biochem Biophys Res Commun; 1985 Feb; 127(1):24-30. PubMed ID: 3977920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 9. Second messengers in platelet aggregation evoked by serotonin and A23187, a calcium ionophore.
    Connor JD; Rasheed H; Gilani AH; Cheema M; Rizvi Z; Saeed SA
    Life Sci; 2001 Oct; 69(23):2759-64. PubMed ID: 11720080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine potentiation of calcium ionophore, A-23187-induced platelet aggregation.
    Shah BH; Saeed SA; Rashid F; Gilani AH
    Adv Exp Med Biol; 1997; 407():537-40. PubMed ID: 9322004
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
    Kornecki E; Ehrlich YH; Lenox RH
    Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
    MacIntyre DE; Bushfield M; MacMillan LJ; Moffat KJ; Murdoch FA; Thomson A; Rossi AG; McNicol A
    Agents Actions Suppl; 1986; 20():45-62. PubMed ID: 3028106
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by amiloride.
    Siffert W; Gengenbach S; Scheid P
    Thromb Res; 1986 Oct; 44(2):235-40. PubMed ID: 3787567
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet aggregation in recombinant-hirudin-anticoagulated blood.
    Glusa E
    Haemostasis; 1991; 21 Suppl 1():116-20. PubMed ID: 1909991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet ADP and serotonin release by carbon monoxide and in cigarette smokers.
    Mansouri A; Perry CA
    Experientia; 1984 May; 40(5):515-7. PubMed ID: 6427001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent.
    Vargaftig BB; Fouque F; Joseph D; Odiot J; Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():429-33. PubMed ID: 6221558
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
    Clemmons RM; Meyers KM
    Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets.
    Vrzheshch PV; Tatarintsev AV; Yershov DE; Varfolomeyev SD
    Thromb Res; 1992 Jun; 66(5):537-47. PubMed ID: 1523610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.